Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.

Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q41917273

about

You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity Pancreatic cancers require autophagy for tumor growth Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma PUMA: a puzzle piece in chloroquine's antimelanoma activity.Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.New concepts in antimalarial use and mode of action in dermatology.Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma.Discovery of autophagy inhibitors with antiproliferative activity in lung and pancreatic cancer cells.The dynamic nature of autophagy in cancer Targeting autophagy addiction in cancer.Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence.Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma.A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer Therapies for interstitial lung disease: past, present and future.Psychomotor Agitation Following Treatment with Hydroxychloroquine.Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.Pharmacokinetic consideration of synthetic DMARDs in rheumatoid arthritis.Hydroxychloroquine preferentially induces apoptosis of CD45RO+ effector T cells by inhibiting autophagy: a possible mechanism for therapeutic modulation of T cells.A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus.Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood.New Perspectives in Rheumatology: Avoiding Antimalarial Toxicity.Research progress of hydroxychloroquine and autophagy inhibitors on cancer.Autophagy and Tumor Metabolism.Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases Increased autophagy in CD4+ T cells of rheumatoid arthritis patients results in T-cell hyperactivation and apoptosis resistance.Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus.The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib.Prevalence and risk factors for chloroquine maculopathy and role of plasma chloroquine and desethylchloroquine concentrations in predicting chloroquine maculopathy.A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.A case of urinary incontinence by hydroxychloroquine in a geriatric patient.Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).

P2860

Q26998971-F5D889B2-8C21-4CAD-873A-7004620464BA Q28066142-2BE66886-5B89-4B99-80C7-1D5F730028A7 Q29620331-8AB4EB32-2BE2-4B1C-8EC6-2EA55069191E Q29622918-66EF0DEF-4E5A-47AB-AAF5-BD70ED7119E1 Q33356363-1663D3CA-1CB2-4BF9-B479-EE2AE0C72E3B Q33422958-6077DB3B-B731-4C67-BAD8-90427A965BDE Q34007922-239CDE94-68C8-498B-B465-7CDCF0D1DA7D Q34372972-5CD1D9E6-9CC6-4972-AB7F-9D67192DEA03 Q34372987-81518D38-B44C-4DE1-B81D-F3663B2ACC2C Q34576062-8889B84E-EABE-4604-83D9-59DADB013B77 Q35086734-EC3114D0-F934-4BF0-840A-CCBB79C5E7BC Q35393206-57AF24E5-F72B-4EC3-8A77-6BCE5ADFB4A7 Q35764384-60DF90A6-F8D8-4C75-8238-4D84981C18C2 Q36240425-C8BAF83C-FAD8-46F2-862C-8C319F23BD40 Q36329393-D988FDF3-B2E1-4053-B206-426B5B1967CF Q37217268-281E1ADE-DFA0-4A27-90BC-7D35146BE664 Q37362642-934BD368-77BF-4070-BE4F-578AB8EE4599 Q37679958-2F0A9DD4-9DAB-49EE-B987-7220AF2EFE7A Q37854742-A93EB8F4-1033-47EE-BF79-B2012E780D09 Q38097969-4A6A0672-C438-4BC3-B9F8-896BB59A3A12 Q38282082-F37F2D87-78BF-4455-97AE-88E14F7D04AB Q38352048-E55366B0-64FB-4676-AE12-DF9CB90B11F3 Q38530430-3DA6F1C3-033E-4854-B73E-A0B84FE4963C Q38561490-2B5BFCA8-51DC-4E7C-8D58-CBDF1CBC5C84 Q38634472-5AB3095C-7E2D-4530-8B04-301EA440BFE7 Q38776952-D7B2BF03-87DF-41F6-86CA-577719D626CE Q38816742-04A3FE76-C481-4CBB-B523-A0B55EEA3D86 Q39021076-62EDD629-A7D6-429C-B791-BA130CCE4187 Q39280823-DA93F96B-B4B7-40EA-B7D5-2C76C17E48CA Q39360987-9B16FACB-6490-487B-BB5A-A6C5104767FA Q39394982-0FDFCDBC-CCA0-49F6-ABEB-978ECE95FE72 Q39997361-EFCD9D35-42C9-4271-B636-3A55C5A50BD8 Q41336601-9661C1F3-3E7D-46DF-AF71-F51B7370526A Q41914711-233A0746-9777-48ED-A7D2-D07D05BD99AD Q41916954-F9963C4C-235A-44FF-B4C2-0933824401C0 Q41926158-8B3BB0F0-3519-4770-9ED6-7F4297E16DE4 Q41926681-FF045DE4-A106-454C-95EF-4C9AF9A6C5DC Q41926759-E9BCF4F8-AAE3-49FF-95FA-BE670136C6A0 Q41927613-7725EB56-2705-473D-979B-53905E4185FD Q41927831-7D576567-EAD0-45D9-9879-A6EB6B94FBD6

P2860

Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q41917273

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Hydroxychloroquine concentrati ...... nts with rheumatoid arthritis.

@en

type

label

Hydroxychloroquine concentrati ...... nts with rheumatoid arthritis.

@en

prefLabel

Hydroxychloroquine concentrati ...... nts with rheumatoid arthritis.

@en

P1433

Q41917273-F405089F-F019-45DB-A830-074D2DC9C67C

P1476

Q41917273-8188A377-ACE5-4625-98E7-C68B2171D8CC

P2093

Q41917273-01C6AA69-C23D-4DE0-B9B4-47DAD478AD36

Q41917273-0E543B24-E809-424A-BEF6-1316BB54C556

Q41917273-12691DC2-A52C-4FED-87DC-6A74147D1B5D

Q41917273-14A99085-5BB6-46B0-8C82-1644F6BE3326

Q41917273-1CA3DD87-D70A-4F09-A0CE-483D047F485E

Q41917273-2F0896ED-4281-47EA-90E6-E2A33AEBE1BE

Q41917273-2F4FD4BB-C36A-4B5C-A63F-2E1950CA9BEA

Q41917273-303556F9-CC54-4322-9858-D90BCA4FA5B0

Q41917273-40B9E2A5-5020-4BB4-BADE-1506857C3ADF

Q41917273-4FAF3425-3B47-4F6F-AA9B-7EB29E73681E

P2860

Q41917273-0032AB95-23E4-48E1-B551-446ED4717B42

Q41917273-04BA3D8B-DEC1-4225-AA97-D6386D91AB2A

Q41917273-1342C06E-1421-4DA5-B86C-083C1BB05374

Q41917273-861D04E5-15CB-4EA7-A82E-F9F4E954EE00

Q41917273-8A81336E-926E-494D-A011-93C49C5178E8

Q41917273-A21CE019-D4F0-4A82-AD7A-8F7CA3E40821

Q41917273-BA019EF9-7C0C-433C-A91D-1CDC64909B4E

Q41917273-C76F9798-60C3-4C69-974E-C0185A0469C4

Q41917273-F21285B2-EEA2-4593-992E-77A2908D2FA4

Q41917273-F884A39E-1393-474C-9A27-CA1D736A5D92

P304

Q41917273-E7808855-4B69-4450-940C-CDA24137E03E

P31

Q41917273-EB9A6352-970D-4FBE-A694-8BCFEA0D22C9

P356

Q41917273-46F0429D-CFCC-4AA6-A539-5678F3098238

P433

Q41917273-F2736FFF-A5FA-45EA-AFB4-9AB5609E086E

P478

Q41917273-85B48E23-AF61-4AB0-B2BA-BAFEB977C3EC

P577

Q41917273-0BCAF1B8-F901-4F40-ADF0-0CB05CC268B4

P5875

Q41917273-EBAA6984-0C78-4511-81C6-2F4A18384130

P698

Q41917273-21758618-7E7C-40B7-8F68-D361F593EA05

P921

Q41917273-BC9AD4F7-340E-496E-A4CC-5B9AA38C55B8

P356

P1433

Arthritis & Rheumatology

P1476

Hydroxychloroquine concentrati ...... nts with rheumatoid arthritis.

@en

P2093

Anthony I Sebba

http://www.w3.org/2001/XMLSchema#string

Bruce A Baethge

http://www.w3.org/2001/XMLSchema#string

Bruce Rothschild

http://www.w3.org/2001/XMLSchema#string

Daniel E Furst

http://www.w3.org/2001/XMLSchema#string

Danny Shen

http://www.w3.org/2001/XMLSchema#string

David Yocum

http://www.w3.org/2001/XMLSchema#string

Fredrick Dietz

http://www.w3.org/2001/XMLSchema#string

Gary R Botstein

http://www.w3.org/2001/XMLSchema#string

George E McLaughlin

http://www.w3.org/2001/XMLSchema#string

Harvey E Golden

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.

Antimalarials in the management of discoid and systemic lupus erythematosus.

A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis.

Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis.

Hydroxychloroquine in the treatment of rheumatoid arthritis.

Pharmacologic actions of 4-aminoquinoline compounds.

Hydroxychloroquine retinopathy.

Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.

Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.

P304

1460-1469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.10307

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11263892

http://www.w3.org/2001/XMLSchema#string

P698

12115175

http://www.w3.org/2001/XMLSchema#string

P921

hydroxychloroquine